Inflammation and coronary artery disease

American Heart Journal

Volumn 150, Issue 1, 2005, Pages 11-18

  Tiong, Alice Y ^a   Brieger, David ^b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CD40 LIGAND; CHEMOATTRACTANT; COLONY STIMULATING FACTOR 1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; GAMMA INTERFERON; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 6; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROSCLEROSIS; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DENDRITIC CELL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC PREDISPOSITION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMUNITY; INFLAMMATION; MACROPHAGE; METABOLIC SYNDROME X; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH2 CELL; THROMBOSIS; VASCULAR SMOOTH MUSCLE;

CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; INFLAMMATION; THROMBOSIS;

EID: 23344444980     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.12.019     Document Type: Review

References (55)

1. Nil Classics in arteriosclerosis research: on experimental cholesterin steatosis and its significance in the origin of some pathological processes by N. Anitschkow and S. Chalatow, translated by Mary Z. Pelias, 1913 Arteriosclerosis 3 1938 178 182
2. P. Weissberg, and J. Rudd E.J. Topol Textbook of cardiovascular medicine by Eric J Topol 2002 Lippincott Philadelphia (Pa)
3. R. Ross Mechanisms of disease: atherosclerosis, an inflammatory disease (review article) N Engl J Med 340 1999 115 126
4. J. Willersen, and D. Kereiakes Endothelial dysfunction Circulation 108 2003 2060 2061
5. D. Price, and J. Loscalzo Cellular adhesion molecules and atherogenesis Am J Cardiol 107 1999 85 97
6. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
7. D.H. Adams, and R. LA Chemokines: leucocyte recruitment and activation cytokines Lancet 349 1997 490 495
8. L. Boring, J. Gosling, and M. Cleary Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
9. V. Kunjathoor, M. Febbraio, and E. Podrez Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified LDL leading to lipid loading in macrophages J Biol Chem 277 2002 49982 49988
10. M. Muzio, G. Natoli, and S. Saccani The human toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6) J Exp Med 187 1998 2097 2101
11. G.K. Hansson, P. Libby, and U. Schönbeck Innate and adaptive immunity in the pathogenesis of atherosclerosis [Review] Circ Res 91 2002 281 291
12. L. Demer, and Y. Tintut Osteopontin: between a rock and a hard place Circ Res 84 1999 250
13. Z. Galis, and J. Khatri Matrix metalloproteinases in vascular remodelling and atherogenesis: the good, the bad and the ugly Circ Res 90 2002 251 252
14. K. Yokoya, H. Takatsu, and T. Suzuki Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: a study based on four serial coronary arteriograms per year Circulation 100 1999 903 909
15. J. Mann, and M. Davies Mechanisms of progression in native coronary artery disease: role of healed plaque disruption Heart 82 1999 265 268
16. O. de Boer, A. van der Waal, and P. Teeling Leukocyte recruitment in rupture prone regions of lipid rich plaques: a prominent role for neovascularization? Cardiovasc Res 41 1999 443 449
17. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
18. A. Newby, and A. Zaltsman Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res 41 1999 345 360
19. P.K. Shah, E. Falk, and J.J. Badimon Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 92 1995 1565 1569
20. X. Fu, S. Kassim, and W. Parks Hypochlorous acid oxygenates the cystein switch domain of pro-matrilysin (MMP-7): a mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase J Biol Chem 276 2001 41279 41287
21. G. Hansson, M. Hellstrand, and L. Rymo Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells J Exp Med 170 1989 1595 1608
22. M. Bennett Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture Cardiovasc Res 41 1999 361 368
23. Y.-J. Geng, L. Henderson, and E. Levesque Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 2200
24. P. Libby Changing concepts of atherogenesis [Minisymposium: immunological aspects of cardiovascular diseases: review] J Intern Med 247 2000 349 358
25. D. Inwald, A. McDowall, and M. Peters CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation Circ Res 92 2003 1041 1048
26. R. Kranzhofer, S.K. Clinton, and K. Ishii Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes Circ Res 79 1996 286 294
27. P. Moreno, E. Falk, and I. Palacios Macrophage infiltration in acute coronary syndromes: implications for plaque rupture Circulation 90 1994 775 778
28. P. Kovanen, M. Kaartinen, and T. Paavonen Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction Circulation 95 1995 1084 1088
29. P. Moreno, K. Purushothaman, and V. Fuster Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability Circulation 105 2002 2504 2511
30. M. Naghavi, P. Libby, and E. Falk From vulnerable plaque to vulnerable patient: part 1 Circulation 108 2003 1664 1672
31. P. Libby, P. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
32. K. Griendling, M. Ushio-Fukai, and B. Lassegue Angiotensin II signalling in vascular smooth muscle cells: new concepts Hypertension 29 1997 366 373
33. M. Creager, and T. Luscher Diabetes and vascular disease, pathophysiology, clinical consequences and medical therapy: part I Circulation 108 2003 1527 1532
34. A. Mokdad, B. Bowman, and E. Ford The continuing epidemics of obesity and diabetes in the United States JAMA 286 2001 1195 2000
35. J. Topper, and M. Gimbrone Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype Mol Med Today 5 1999 40 46
36. Y. Yamada, H. Izawa, and S. Ichihara Prediction of the risk of myocardial infarction from polymorphisms in candidate genes N Engl J Med 347 2002 1916 1923
37. S. Kiechl, G. Egger, and M. Mayr Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study Circulation 103 2001 1064 1070
38. M. Naghavi, P. Wyde, and S. Litovsky Influenza infection exerts prominent inflammatory and thrombotic effects on atherosclerotic plaques of apolipoprotein E-deficient mice Circulation 107 2003 762 768
39. M. Kalayoglu, P. Libby, and G. Byrne Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease JAMA 288 2002 2724 2731
40. M. Dunne Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (Weekly Intervention with Zithromax [azithromycin] for Atherosclerosis and its Related Disorders) trial J Infect Dis 181 Suppl. 3 2000 S572 S578
41. J. Cleland, P. Loh, and N. Freemantle Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial Eur J Heart Fail 6 2004 787 791
42. G. Serneri, R. Abbate, and A. Gori Transient intermittent lymphocyte activation is responsible for the instability of angina Circulation 86 1992 790 797
43. S. Stemme, B. Faber, and J. Holm T lymphocytes from human atherosclerotic plaques recognize oxidized LDL Proc Natl Acad Sci U S A 92 1995 3893 3897
44. G. Liuzzo, S. Kopecky, and R. Frye Perturbation of the T-cell repertoire in patients with unstable angina Circulation 100 1999 2135 2139
45. +CD28null T cells clonally expanded in rheumatoid arthritis J Immunol 165 1998 1138 1145
46. V. Pasceri, and E. Yeh A tale of two diseases: atherosclerosis and rheumatoid arthritis Circulation 100 1999 2124 2126
47. C. Turesson, A. Jarenros, and L. Jacobsson Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study Ann Rheum Dis 63 2004 952 955
48. B. Kwak, S. Myit, and F. Mach Statins as a newly recognized type of immunomodulator Nat Med 6 2000 1399 1402
49. L. Lacoste, J. Lam, and J. Hung Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction Circulation 92 1995 3172 3177
50. C. Heeschen, S. Dimmeler, and C. Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
51. P. Ridker, N. Brown, and D. Vaughan Established and emerging plasma biomarkers in the prediction of first atherothrombotic events Circulation 109 Suppl. 2004 6 19
52. G. Blake, and P. Ridker Inflammatory bio-markers and cardiovascular risk prediction J Intern Med 252 2002 283 294
53. U. Schonbeck, N. Varo, and P. Libby Soluble CD40L and cardiovascular risk in women Circulation 104 2001 2266 2268
54. P. Calabro, J. Willerson, and E. Yeh Inflammatory cytokines stimulated CRP production by human coronary artery smooth muscle cells Circulation 108 2003 1930 1932
55. P. Szmitko, C. Wang, and R. Weisel New inflammatory markers and endothelial cell activation: part I Circulation 108 2003 1917 1923